Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

Is Adherence to Imatinib Mesylate Treatment Among Patients with Chronic Myeloid Leukemia Associated with Better Clinical Outcomes in Qatar?

Show other versions (1)
Bibliographic Details
Main Authors: Nader I. Al-Dewik, Hisham M. Morsi, Muthanna M. Samara, Rola S. Ghasoub, Cinquea C. Gnanam, Subi K. Bhaskaran, Abdulqadir J. Nashwan, Rana M. Al-Jurf, Mohamed A. Ismail, Mohammed M. AlSharshani, Ali A. AlSayab, Tawfeg I. Ben-Omran, Rani B. Khatib, Mohamed A. Yassin
Format: Article
Language:English
Published: SAGE Publishing 2016-10-01
Series:Clinical Medicine Insights: Oncology
Online Access:http://www.la-press.com/is-adherence-to-imatinib-mesylate-treatment-among-patients-with-chroni-article-a5939

Internet

http://www.la-press.com/is-adherence-to-imatinib-mesylate-treatment-among-patients-with-chroni-article-a5939

Similar Items